Mind Medicine
(NASDAQ:MNMD)
$8.08
-0.045[-0.55%]
Last update: 9:00AM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$36.00
Lowest Price Target1
$6.00
Consensus Price Target1
$19.33

Mind Medicine Stock (NASDAQ:MNMD), Analyst Ratings, Price Targets, Predictions

Mind Medicine Inc has a consensus price target of $19.33, established from looking at the 36 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, HC Wainwright & Co., and Leerink Partners on May 13, 2024, May 10, 2024, and April 15, 2024. With an average price target of $25 between Oppenheimer, HC Wainwright & Co., and Leerink Partners, there's an implied 209.41% upside for Mind Medicine Inc from these 3 analyst ratings.

Analyst Trend
1
Feb
4
Mar
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Oppenheimer
HC Wainwright & Co.
Leerink Partners
RBC Capital
Roth MKM

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Mind Medicine

Buy NowGet Alert
05/13/2024Buy Now147.52%Oppenheimer
Francois Brisebois
$29 → $20ReiteratesOutperform → OutperformGet Alert
05/10/2024Buy Now333.17%HC Wainwright & Co.
Patrick Trucchio
$75 → $35MaintainsBuyGet Alert
04/15/2024Buy Now147.52%Leerink Partners
Rudy Li
→ $20Initiates → OutperformGet Alert
03/14/2024Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75ReiteratesBuy → BuyGet Alert
03/08/2024Buy Now172.28%RBC Capital
Brian Abrahams
$15 → $22MaintainsOutperformGet Alert
03/07/2024Buy Now345.54%Roth MKM
Jonathan Aschoff
$25 → $36MaintainsBuyGet Alert
03/01/2024Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75ReiteratesBuy → BuyGet Alert
02/29/2024Buy Now85.64%RBC Capital
Brian Abrahams
$14 → $15MaintainsOutperformGet Alert
10/23/2023Buy Now-13.37%RBC Capital
Brian Abrahams
→ $7ReiteratesOutperform → OutperformGet Alert
08/22/2023Buy Now-13.37%Cantor Fitzgerald
Charles Duncan
→ $7ReiteratesOverweight → OverweightGet Alert
08/04/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75Reiterates → BuyGet Alert
08/04/2023Buy Now-13.37%RBC Capital
Brian Abrahams
$5 → $7MaintainsOutperformGet Alert
08/04/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21ReiteratesBuy → BuyGet Alert
07/10/2023Buy Now-38.12%RBC Capital
Brian Abrahams
→ $5ReiteratesOutperform → OutperformGet Alert
06/28/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
$75 → $75ReiteratesBuy → BuyGet Alert
06/21/2023Buy Now-38.12%RBC Capital
Brian Abrahams
ReiteratesOutperform → OutperformGet Alert
06/20/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21ReiteratesBuy → BuyGet Alert
05/18/2023Buy Now-13.37%Cantor Fitzgerald
Charles Duncan
→ $7Reiterates → OverweightGet Alert
05/18/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21ReiteratesBuy → BuyGet Alert
05/09/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75Reiterates → BuyGet Alert
05/05/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21Reiterates → BuyGet Alert
04/18/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75Reiterates → BuyGet Alert
04/14/2023Buy Now172.28%Oppenheimer
Francois Brisebois
→ $22Reiterates → OutperformGet Alert
04/14/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21Reiterates → BuyGet Alert
03/16/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75Reiterates → BuyGet Alert
03/10/2023Buy Now-38.12%RBC Capital
Brian Abrahams
→ $5Reiterates → OutperformGet Alert
03/10/2023Buy Now159.9%EF Hutton
Elemer Piros
→ $21Reiterates → BuyGet Alert
01/19/2023Buy Now828.22%HC Wainwright & Co.
Patrick Trucchio
→ $75Reiterates → BuyGet Alert
12/16/2022Buy Now159.9%EF Hutton
Elemer Piros
→ $21Initiates → BuyGet Alert
11/16/2022Buy Now-38.12%RBC Capital
Brian Abrahams
→ $5Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Mind Medicine (MNMD)?

A

The latest price target for Mind Medicine (NASDAQ: MNMD) was reported by Oppenheimer on May 13, 2024. The analyst firm set a price target for $20.00 expecting MNMD to rise to within 12 months (a possible 147.52% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Mind Medicine (MNMD)?

A

The latest analyst rating for Mind Medicine (NASDAQ: MNMD) was provided by Oppenheimer, and Mind Medicine reiterated their outperform rating.

Q

When was the last upgrade for Mind Medicine (MNMD)?

A

There is no last upgrade for Mind Medicine.

Q

When was the last downgrade for Mind Medicine (MNMD)?

A

There is no last downgrade for Mind Medicine.

Q

When is the next analyst rating going to be posted or updated for Mind Medicine (MNMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mind Medicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mind Medicine was filed on May 13, 2024 so you should expect the next rating to be made available sometime around May 13, 2025.

Q

Is the Analyst Rating Mind Medicine (MNMD) correct?

A

While ratings are subjective and will change, the latest Mind Medicine (MNMD) rating was a reiterated with a price target of $29.00 to $20.00. The current price Mind Medicine (MNMD) is trading at is $8.08, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.